Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$73.71BHealthcare Market cap, Sector
Masimo
MASI$9.42BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 70 MASI
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS7wins
0winsMASI
84B
F44
87A
B70
92A
F44
66C
F30
75B
D57
91A
D46
95A
F37
Side-by-side metrics
| Metric | JSLL.NS | MASI |
|---|---|---|
| Market cap | Winner: $73.71B | $9.42B |
| P/E (TTM) | Winner: 33.3x | 122.3x |
| EV/EBIT | Winner: 24.1x | 31.1x |
| ROIC (TTM) | Winner: 39.15% | 18.28% |
| Gross margin | Winner: 88.58% | 61.73% |
| Net margin | Winner: 27.68% | 4.9% |
| Revenue CAGR 5y | Winner: 57.81% | 5.36% |
| EPS CAGR 5y | 86.67% | - |
| Debt / Equity | Winner: 0.3x | 0.6x |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- Revenue CAGR 5y57.81%vs 5.36%+91%
- Market cap$73.71Bvs $9.42B+87%
- Net margin27.68%vs 4.9%+82%
- P/E (TTM)33.3xvs 122.3x+73%
MASI leads on
No clear edges - the other side wins or ties on every measured metric.
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.